Impact of Postoperative Morbidity on Long-Term Survival After Resection for Colorectal Liver Metastases

Annals of Surgical Oncology

Volumn 23, Issue , 2016, Pages 929-937

  Tanaka, Kuniya ^a   Kumamoto, Takafumi ^a   Nojiri, Kazunori ^a   Matsuyama, Ryusei ^a   Takeda, Kazuhisa ^a   Endo, Itaru ^a  

^a YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE;

ABDOMINAL ABSCESS; ABDOMINAL BLEEDING; ADULT; ADVANCED CANCER; AGED; AMINOTRANSFERASE BLOOD LEVEL; ANASTOMOSIS LEAKAGE; ANGINA PECTORIS; ARTICLE; ASCITES; ATELECTASIS; BILE DUCT FISTULA; BILOMA; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CLINICAL EVALUATION; COLORECTAL LIVER METASTASIS; COMPARATIVE STUDY; DEEP VEIN THROMBOSIS; DELIRIUM; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; FEVER; FUNGAL EYE INFECTION; GASTROINTESTINAL DISEASE; GASTROINTESTINAL HEMORRHAGE; HEART ARRHYTHMIA; HEMATOMA; HUMAN; HYPERBILIRUBINEMIA; INFECTIOUS DIARRHEA; INTESTINE OBSTRUCTION; LIVER ABSCESS; LIVER DISEASE; LIVER FAILURE; LIVER RESECTION; LIVER VEIN THROMBOSIS; LONG TERM SURVIVAL; LUNG HEMORRHAGE; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE; OVERALL SURVIVAL; PLEURA EFFUSION; PNEUMONIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE THROMBOSIS; RETROSPECTIVE STUDY; SUBCUTANEOUS HEMORRHAGE; SUBPHRENIC ABSCESS; SURGICAL INFECTION; SURGICAL PATIENT; TREATMENT OUTCOME; ADJUVANT CHEMOTHERAPY; COLORECTAL TUMOR; LIVER TUMOR; MIDDLE AGED; PATHOLOGY; SECONDARY; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TIME FACTOR; TUMOR VOLUME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TIME FACTORS; TUMOR BURDEN;

EID: 77956912140     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1352-1     Document Type: Article

References (35)

1. Laurent C, Sa Cunha A, Couderc P, Rullier E, Saric J. Influence of postoperative morbidity on long-term survival following liver resection for colorectal metastases. Br J Surg. 2003;90:1131–6.
2. Malafosse R, Penna C, Sa Cunha A, Nordlinger B. Surgical management of hepatic metastases from colorectal malignancies. Ann Oncol. 2001;12:887–94.
3. Mynster T, Christensen IJ, Moesgaard F, Nielsen HJ. Effects of the combination of blood transfusion and postoperative infectious complications on prognosis after surgery for colorectal cancer. Danish RANX05 Colorectal Cancer Study Group. Br J Surg. 2000;87:1553–62.
4. Hirai T, Yamashita Y, Mukaida H, Kuwahara M, Inoue H, Toge T. Poor prognosis in esophageal cancer patients with postoperative complications. Surg Today. 1998;28:576–9.
5. Howard TJ, Krug JE, Yu J, Zyromski NJ, Schmidt CM, Jacobson LE, et al. A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon’s contribution to long-term survival in pancreatic cancer. J Gastrointest Surg. 2006;10:1338–46.
6. de Melo GM, Ribeiros KC, Kowalski LP, Deheinzelin D. Risk factors for postoperative complications in oral cancer and their prognostic implications. Arch Otolaryngol Head Neck Surg. 2001;127:828–33.
7. Schiesser M, Chen JW, Maddern GJ, Padbury RT. Perioperative morbidity affects long-term survival in patients following liver resection for colorectal metastases. J Gastrointest Surg. 2008;12:1054–60.
8. Watine J, Miédougé M, Friedberg B. Carcinoembryonic antigen as an independent prognostic factor of recurrence and survival in patients resected for colorectal liver metastases. Dis Colon Rectum. 2001;44:1791–9.
9. Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, Hoff PM, et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol. 2006;24:2065–72.
10. Aloia T, Sebagh M, Plasse M, Karam V, Levi F, Giacchetti S, et al. Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol. 2006;24:4983–90.
11. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.
12. Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187–96.
13. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst. 2000;92:205–6.
14. Panis Y, Ribeiro J, Chrétien Y, Nordlinger B. Dormant liver metastases: an experimental study. Br J Surg. 1992;79:221–3.
15. Younes RN, Rogatko A, Brennan MF. The influence of intraoperative hypotension and perioperative blood transfusion on disease-free survival in patients with complete resection of colorectal liver metastases. Ann Surg. 1991;214:107–13.
16. Imamura H, Seyama Y, Kokudo N, Maema A, Sugawara Y, Sano K, et al. One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg. 2003;138:1198–206; discussion 1206.
17. Poon RT, Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, et al. Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg. 2004;240:698–708; discussion 708–10.
18. Tartter PI. The association of perioperative blood transfusion with colorectal cancer recurrence. Ann Surg. 1992;216:633–8.
19. Hyman NH, Foster RS Jr, DeMeules JE, Costanza MC. Blood transfusions and survival after lung cancer resection. Am J Surg. 1985;149:502–7.
20. Johnson JT, Taylor FH, Thearle PB. Blood transfusion and outcome in stage III head and neck carcinoma. Arch Otolaryngol Head Neck Surg. 1987;113:307–10.
21. Blajchman MA, Bordin JO. The tumor growth-promoting effect of allogeneic blood transfusions. Immunol Invest. 1995;24:311–17.
22. Mathiesen O, Lund L, Brodthagen U, Gandrup P, Grunnet N, Balslev I, et al. The effect of previous blood transfusion on lymphocyte subsets and natural killer cell function in patients with colorectal cancer. Vox Sang. 1994;67:36–41.
23. Jubert AV, Lee ET, Hersh EM, McBride CM. Effects of surgery, anesthesia and intraoperative blood loss on immunocompetence. J Surg Res. 1973;15:399–403.
24. Stephan RN, Kupper TS, Geha AS, Baue AE, Chaudry IH. Hemorrhage without tissue trauma produces immunosuppression and enhances susceptibility to sepsis. Arch Surg. 1987;122:62–8.
25. Younes RN, Rogatko A, Vydelingum NA, Brennan MF. Effects of hypovolemia and transfusion on tumor growth in MCA-tumor-bearing rats. Surgery. 1991;109:307–12.
26. Tanaka K, Shimada H, Ueda M, Matsuo K, Endo I, Togo S. Role of hepatectomy in treating multiple bilobar colorectal cancer metastases. Surgery. 2008;143:259–70.
27. Kornprat P, Jarnagin WR, Gonen M, Dematteo RP, Fong Y, Blumgart LH, et al. Outcome after hepatectomy for multiple (four or more) colorectal metastases in the era of effective chemotherapy. Ann Surg Oncol. 2007;14:1151–60.
28. Tanaka K, Shimada H, Kubota K, Ueda M, Endo I, Sekido H, et al. Effectiveness of prehepatectomy intra-arterial chemotherapy for multiple bilobar colorectal cancer metastases to the liver: a clinicopathologic study of peritumoral vasculobiliary invasion. Surgery. 2005;137:156–64.
29. Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, Bouvier AM. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg. 2006;244:254–9.
30. Figueras J, Valls C, Rafecas A, Fabregat J, Ramos E, Jaurrieta E. Resection rate and effect of postoperative chemotherapy on survival after surgery for colorectal liver metastases. Br J Surg. 2001;88:980–5.
31. Portier G, Elias D, Bouche O, Rougier P, Bosset JF, Saric J, et al. Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. J Clin Oncol. 2006;24:4976–82.
32. Parks R, Gonen M, Kemeny N, Jarnagin W, D’Angelica M, DeMatteo R, et al. Adjuvant chemotherapy improves survival after resection of hepatic colorectal metastases: analysis of data from two continents. J Am Coll Surg. 2007;204:753–63.
33. Adam R, Pascal G, Castaing D, Azoulay D, Delvart V, Paule B, et al. Tumor progression while on chemotherapy. A contraindication to liver resection for multiple colorectal metastases? Ann Surg. 2004;240:1052–64.
34. Karoui M, Penna C, Amin-Hashem M, Mitry E, Benoist S, Franc B, et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg. 2006;243:1–7.
35. Tanaka K, Shimada H, Ueda M, Matsuo K, Endo I, Sekido H, et al. Perioperative complications after hepatectomy with or without intra-arterial chemotherapy for bilobar colorectal cancer liver metastases. Surgery. 2006;139:599–607.